Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

KemPharm Shares Outstanding 2014-2020 | KMPH

KemPharm shares outstanding from 2014 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
KemPharm Annual Shares Outstanding
(Millions of Shares)
2020 4
2019 2
2018 1
2017 1
2016 1
2015 0
2014 0
2013 0
KemPharm Quarterly Shares Outstanding
(Millions of Shares)
2020-12-31 4
2020-09-30 4
2020-06-30 4
2020-03-31 3
2019-12-31 2
2019-09-30 2
2019-06-30 2
2019-03-31 2
2018-12-31 1
2018-09-30 1
2018-06-30 1
2018-03-31 1
2017-12-31 1
2017-09-30 1
2017-06-30 1
2017-03-31 1
2016-12-31 1
2016-09-30 1
2016-06-30 1
2016-03-31 1
2015-12-31 0
2015-09-30 1
2015-06-30 1
2015-03-31 0
2014-12-31 0
2014-09-30 0
2014-06-30 0
2014-03-31 0
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.255B $0.013B
KemPharm Inc. is a specialty pharmaceutical company which is engaged in the discovery and development of new molecular entity prodrugs. Its product candidates include KP201/APAP, KP511/ER and KP606/ER for the treatment of pain; KP415 for the treatment of attention deficit hyperactivity disorder and KP303 for the treatment of central nervous system disorders, which are in preclinical trail stage. The Company through its LAT platform technology generate prodrug. KemPharm Inc. is based in CORALVILLE, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $80.149B 43.83
Takeda Pharmaceutical (TAK) Japan $53.142B 9.73
Astellas Pharma (ALPMY) Japan $27.964B 17.26
Eisai (ESALY) Japan $19.909B 22.08
Catalent (CTLT) United States $18.616B 49.26
Grifols, S.A (GRFS) Spain $12.513B 14.56
Jazz Pharmaceuticals (JAZZ) Ireland $9.468B 15.81
United Therapeutics (UTHR) United States $9.247B 17.96
Neurocrine Biosciences (NBIX) United States $9.091B 20.95
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.997B 0.00
IPSEN SA ADR (IPSEY) France $7.885B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $7.070B 0.00
Evotec AG (EVTCY) Germany $6.788B 458.33
Ionis Pharmaceuticals (IONS) United States $5.798B 0.00
Orion OYJ (ORINY) Finland $5.789B 20.11
Sage Therapeutics (SAGE) United States $4.288B 0.00
Hypermarcas (HYPMY) Brazil $3.953B 15.60
Turning Point Therapeutics (TPTX) United States $3.516B 0.00
Nektar Therapeutics (NKTR) United States $3.429B 0.00
PTC Therapeutics (PTCT) United States $3.257B 0.00
ChemoCentryx (CCXI) United States $3.159B 0.00
Relay Therapeutics (RLAY) United States $2.916B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.906B 18.00
Revolution Medicines (RVMD) United States $2.812B 0.00
Cronos Group (CRON) Canada $2.778B 0.00
Pacira BioSciences (PCRX) United States $2.748B 46.41
Tilray (TLRY) Canada $2.729B 0.00
Corcept Therapeutics (CORT) United States $2.643B 26.51
Organogenesis Holdings (ORGO) United States $2.624B 157.69
Xencor (XNCR) United States $2.407B 0.00
USANA Health Sciences (USNA) United States $2.081B 17.22
BioCryst Pharmaceuticals (BCRX) United States $1.974B 0.00
FibroGen (FGEN) United States $1.874B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.716B 13.49
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.700B 10.90
Heron Therapeutics (HRTX) United States $1.625B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.513B 0.00
Translate Bio (TBIO) United States $1.488B 0.00
AlloVir (ALVR) United States $1.464B 0.00
ImmunoGen (IMGN) United States $1.462B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.440B 0.00
Sundial Growers (SNDL) Canada $1.397B 0.00
Indivior (INVVY) United States $1.381B 0.00
Aclaris Therapeutics (ACRS) United States $1.371B 0.00
Endo (ENDP) Ireland $1.298B 1.96
Ocular Therapeutix (OCUL) United States $1.124B 0.00
Zogenix (ZGNX) United States $1.049B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.031B 0.00
Trillium Therapeutics (TRIL) Canada $0.951B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.897B 0.00
Bioventus (BVS) United States $0.865B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
4D Molecular Therapeutics (FDMT) $0.852B 0.00
Aerie Pharmaceuticals (AERI) United States $0.819B 0.00
Collegium Pharmaceutical (COLL) United States $0.803B 30.01
Ardelyx (ARDX) United States $0.796B 0.00
Esperion Therapeutics (ESPR) United States $0.775B 0.00
Karyopharm Therapeutics (KPTI) United States $0.709B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.650B 0.00
Rafael Holdings (RFL) United States $0.636B 0.00
Chinook Therapeutics (KDNY) United States $0.622B 0.00
Harpoon Therapeutics (HARP) United States $0.614B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.604B 0.00
VAXART, INC (VXRT) United States $0.596B 0.00
Siga Technologies (SIGA) United States $0.581B 9.71
KalVista Pharmaceuticals (KALV) United States $0.574B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.547B 0.00
Nanobiotix S.A (NBTX) France $0.542B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.507B 0.00
Sigilon Therapeutics (SGTX) $0.504B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.478B 0.00
TherapeuticsMD (TXMD) United States $0.460B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.456B 10.71
Spectrum Pharmaceuticals (SPPI) United States $0.447B 0.00
Molecular Templates (MTEM) United States $0.446B 0.00
Altimmune (ALT) United States $0.439B 0.00
Akebia Therapeutics (AKBA) United States $0.434B 0.00
Flexion Therapeutics (FLXN) United States $0.430B 0.00
AVITA Medical (RCEL) United States $0.430B 0.00
Summit Therapeutics (SMMT) United States $0.427B 0.00
Jounce Therapeutics (JNCE) United States $0.399B 0.00
Foghorn Therapeutics (FHTX) United States $0.391B 0.00
Nature's Sunshine Products (NATR) United States $0.390B 18.59
PROFOUND MEDICL (PROF) Canada $0.380B 0.00
DURECT (DRRX) United States $0.364B 0.00
Acutus Medical (AFIB) United States $0.363B 0.00
MEI Pharma (MEIP) United States $0.362B 0.00
Innate Pharma SA (IPHYF) France $0.352B 0.00
Redhill Biopharma (RDHL) Israel $0.305B 0.00
Oncternal Therapeutics (ONCT) United States $0.284B 0.00
Clever Leaves Holdings (CLVR) United States $0.264B 0.00
Alpine Immune Sciences (ALPN) United States $0.263B 0.00
VYNE Therapeutics (VYNE) United States $0.247B 0.00
Infinity Pharmaceuticals (INFI) United States $0.246B 0.00
Taiwan Liposome (TLC) Taiwan $0.244B 0.00
Inotiv (NOTV) United States $0.228B 0.00
Xeris Pharmaceuticals (XERS) United States $0.228B 0.00
CASI Pharmaceuticals (CASI) United States $0.219B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.218B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.213B 0.00
4D Pharma (LBPS) United Kingdom $0.210B 0.00
Sierra Oncology (SRRA) Canada $0.202B 0.00
Lannett Co Inc (LCI) United States $0.200B 6.71
Iterum Therapeutics (ITRM) Ireland $0.189B 0.00
OptiNose (OPTN) United States $0.185B 0.00
Progenity (PROG) United States $0.182B 0.00
IMV INC (IMV) Canada $0.181B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.179B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.174B 0.00
CTI BioPharma (CTIC) United States $0.170B 0.00
Adherex Technologies (FENC) United States $0.162B 0.00
Jaguar Animal Health (JAGX) United States $0.161B 0.00
Heat Biologics (HTBX) United States $0.160B 0.00
Novan (NOVN) United States $0.159B 0.00
Gain Therapeutics (GANX) United States $0.153B 0.00
Calithera Biosciences (CALA) United States $0.150B 0.00
Champions Oncology (CSBR) United States $0.150B 0.00
SCYNEXIS (SCYX) United States $0.150B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.149B 0.00
Qilian Holding Group (QLI) China $0.148B 0.00
Onconova Therapeutics (ONTX) United States $0.144B 0.00
Vivos Therapeutics (VVOS) $0.140B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.138B 0.00
Aquestive Therapeutics (AQST) United States $0.136B 0.00
Concert Pharmaceuticals (CNCE) United States $0.135B 0.00
Aziyo Biologics (AZYO) United States $0.133B 0.00
MediWound (MDWD) Israel $0.131B 0.00
Otonomy (OTIC) United States $0.130B 0.00
GlycoMimetics (GLYC) United States $0.129B 0.00
Lipocine (LPCN) United States $0.124B 0.00
IsoRay (ISR) United States $0.116B 0.00
Genocea Biosciences (GNCA) United States $0.116B 0.00
Nutriband (NTRB) United States $0.114B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.106B 0.00
PolarityTE (PTE) United States $0.104B 0.00
Natural Alternatives (NAII) United States $0.103B 27.97
Minerva Neurosciences (NERV) United States $0.103B 40.17
Adamis Pharmaceuticals (ADMP) United States $0.101B 0.00
Savara (SVRA) United States $0.100B 0.00
AIM ImmunoTech (AIM) United States $0.096B 0.00
Regulus Therapeutics (RGLS) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.084B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.083B 0.00
Assertio Holdings (ASRT) United States $0.082B 0.00
Recro Pharma (REPH) United States $0.081B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
Baudax Bio (BXRX) United States $0.071B 0.00
ProPhase Labs (PRPH) United States $0.070B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.069B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.067B 0.00
India Globalization Capital (IGC) United States $0.064B 0.00
Sigyn Therapeutics (SIGY) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Brickell Biotech (BBI) United States $0.055B 0.00
Biomerica (BMRA) United States $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
Inhibikase Therapeutics (IKT) United States $0.051B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.051B 0.00
HANCOCK JAFFE (HJLI) United States $0.049B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.044B 59.40
Mannatech (MTEX) United States $0.042B 7.54
Viracta Therapeutics (VIRX) United States $0.040B 0.00
Can-Fite Biopharma (CANF) Israel $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.031B 0.00
Phio Pharmaceuticals Cop (PHIO) United States $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Petros Pharmaceuticals (PTPI) United States $0.028B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 15.80
SHINECO INC (TYHT) China $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
JanOne (JAN) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00